Loading...
Phibro Q3 2025 Earnings Report
Phibro Animal Health Corporation reported its Q3 2025 earnings with significant increases in net sales, net income, and operating income compared to the prior year.
Key Takeaways
Phibro Animal Health Corporation delivered strong financial results for the third quarter of fiscal year 2025, with net sales increasing by 32% and net income surging by 148% compared to the same period last year. The growth was primarily driven by the acquisition of Zoetis's medicated feed additive portfolio, which significantly boosted Animal Health segment revenues.
Net sales increased by 32% to $347.8 million, primarily due to the acquisition of Zoetis's MFA portfolio.
Net income grew by 148% to $20.88 million, reflecting improved operating performance.
Operating income increased by 68% to $33.515 million, driven by favorable gross profit.
Adjusted EBITDA saw an 85% increase to $54.886 million, indicating strong operational efficiency.
Phibro
Phibro
Phibro Revenue by Segment
Revenue by Segment
Animal Health Revenue
CapyFin.comMFAs and Other Revenue
CapyFin.comNutritional Specialties Revenue
CapyFin.comVaccines Revenue
CapyFin.comMineral Nutrition Revenue
CapyFin.comPerformance Products Revenue
CapyFin.com Forward Guidance
The company expects adequate liquidity for at least the next twelve months, supported by cash on hand, operating cash flows, and financing arrangements under the 2024 Credit Facility. They anticipate compliance with debt covenants but acknowledge potential risks from macroeconomic conditions and conflicts.
Positive Outlook
- Sufficient cash on hand and operating cash flows to support ongoing cash needs.
- Availability of borrowings under the 2024 Credit Facility provides financial flexibility.
- Expectation to comply with terms of 2024 Credit Facilities covenants based on operating plan.
- Diversified product portfolio and global presence mitigate some market risks.
- Continued investment in expanding production capacity and productivity improvements.
Challenges Ahead
- Uncertainty regarding future funding requirements if adverse operating results or covenant violations occur.
- Global economic conditions and macroeconomic disruptions could affect liquidity.
- Ongoing conflicts (Russia/Ukraine, Middle East) pose risks to operations and financial stability.
- Debt covenants may restrict ability to invest or pay dividends.
- Potential for increased tariffs or retaliatory measures impacting profitability and customer base.
Revenue & Expenses
Visualization of income flow from segment revenue to net income